Emerging biological roles for erythropoietin in the nervous system
M Brines, A Cerami - Nature Reviews Neuroscience, 2005 - nature.com
Erythropoietin mediates an evolutionarily conserved, ancient immune response that limits
damage to the heart, the nervous system and other tissues following injury. New evidence …
damage to the heart, the nervous system and other tissues following injury. New evidence …
MAPK signaling pathways in the regulation of hematopoiesis
CR Geest, PJ Coffer - Journal of leukocyte biology, 2009 - academic.oup.com
Relevance of mitogen-activated protein kinases ERK, JNK, and p38 in the regulation of
myeloid differentiation. The MAPKs are a family of serine/threonine kinases that play an …
myeloid differentiation. The MAPKs are a family of serine/threonine kinases that play an …
Supramolecular Self‐Assembly‐Facilitated Aggregation of Tumor‐Specific Transmembrane Receptors for Signaling Activation and Converting Immunologically Cold …
J Li, Y Fang, Y Zhang, H Wang, Z Yang… - Advanced …, 2021 - Wiley Online Library
Supramolecular self‐assembling peptide systems are attracting increasing interest in the
field of cancer theranostics. Additionally, transformation of the immunologically cold tumor …
field of cancer theranostics. Additionally, transformation of the immunologically cold tumor …
[HTML][HTML] A novel protective effect of erythropoietin in the infarcted heart
CJ Parsa, A Matsumoto, J Kim, RU Riel… - The Journal of …, 2003 - Am Soc Clin Investig
Erythropoietin (EPO) has been shown to protect neurons from ischemic stroke, but can also
increase thrombotic events and mortality rates in patients with ischemic heart disease. We …
increase thrombotic events and mortality rates in patients with ischemic heart disease. We …
An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7
I Nagaoka, H Tamura, M Hirata - The Journal of Immunology, 2006 - journals.aai.org
Peptide antibiotics possess the potent antimicrobial activities against invading
microorganisms and contribute to the innate host defense. An antibacterial cathelicidin …
microorganisms and contribute to the innate host defense. An antibacterial cathelicidin …
Apoptotic mechanisms in the control of erythropoiesis
U Testa - Leukemia, 2004 - nature.com
Erythropoiesis is a complex multistep process encompassing the differentiation of
hemopoietic stem cells to mature erythrocytes. The steps involved in this complex …
hemopoietic stem cells to mature erythrocytes. The steps involved in this complex …
Red blood cell physiology in critical illness
M Scharte, MP Fink - Critical care medicine, 2003 - journals.lww.com
Red blood cell physiology in critical illness : Critical Care Medicine Red blood cell physiology
in critical illness : Critical Care Medicine SCCM Pediatric Critical Care Medicine Critical Care …
in critical illness : Critical Care Medicine SCCM Pediatric Critical Care Medicine Critical Care …
[HTML][HTML] Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells
JH Weishaupt, G Rohde, E Pölking… - … & visual science, 2004 - iovs.arvojournals.org
purpose. Erythropoietin (EPO) modulates erythropoiesis by inhibiting apoptosis in
erythrocyte progenitors. Recently, EPO has been shown to be protective in experimental …
erythrocyte progenitors. Recently, EPO has been shown to be protective in experimental …
[HTML][HTML] Cardioprotective effects of erythropoietin in the reperfused ischemic heart: a potential role for cardiac fibroblasts
CJ Parsa, J Kim, RU Riel, LS Pascal… - Journal of Biological …, 2004 - ASBMB
Erythropoietin has recently been shown to have effects beyond hematopoiesis such as
prevention of neuronal and cardiac apoptosis secondary to ischemia. In this study, we …
prevention of neuronal and cardiac apoptosis secondary to ischemia. In this study, we …
Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation
MA Park, G Zhang, AP Martin, H Hamed… - Cancer biology & …, 2008 - Taylor & Francis
We recently noted that low doses of sorafenib and vorinostat interact in a synergistic fashion
to kill carcinoma cells by activating CD95, and this drug combination is entering phase I …
to kill carcinoma cells by activating CD95, and this drug combination is entering phase I …